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Attention is critical to high-level cognition, and attentional deficits
are a hallmark of cognitive dysfunction. A key transmitter for atten-
tional control is acetylcholine, but its cellular actions in attention-
controlling areas remain poorly understood. Here we delineate how
muscarinic and nicotinic receptors affect basic neuronal excitability and
attentional control signals in different cell types in macaque frontal eye
field.We found that broad spiking and narrow spiking cells both require
muscarinic and nicotinic receptors for normal excitability, thereby
affecting ongoing or stimulus-driven activity. Attentional control signals
depended on muscarinic, not nicotinic receptors in broad spiking cells,
while they depended on both muscarinic and nicotinic receptors in
narrow spiking cells. Cluster analysis revealed that muscarinic and
nicotinic effects on attentional control signalswere highly selective even
for different subclasses of narrow spiking cells and of broad spiking
cells. These results demonstrate that cholinergic receptors are critical to
establish attentional control signals in the frontal eye field in a cell type-
specific manner.
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Acetylcholine (ACh) is a key neuromodulator critical to high-level cognitive functions, such as learning, memory, and
attention (1–3). Cholinergic deficits are a hallmark of attentional
dysfunctions associated with Alzheimer disease, and drugs that
enhance ACh levels in the brain are used to alleviate some of the
associated symptoms (4). Cellular signatures of attention in
sensory and high-level association areas are well studied, but
their neuropharmacological underpinnings remain poorly un-
derstood. Cellular signatures of attention include increased firing
rates (5, 6), reduced rate variability (7–9), reduced noise corre-
lation (8–11), and altered oscillatory activity (12–14). These
modulations are driven by cortico-cortical feedback connections
(15, 16), and one of the key areas mediating these effects is the
frontal eye field (FEF) (14–19).
Attention-induced rate changes in primary visual cortex (V1)
are dependent on muscarinic, not nicotinic ACh receptors (20),
while alterations of attention-induced changes to rate variability
and pairwise noise correlations depend on N-methyl-D-aspartate
(NMDA) receptors (8). Clinical and behavioral studies suggest
that the main attention-related benefits from cholinergic en-
hancement are due to increased activity not in sensory areas, but
in frontal and parietal association areas (21, 22), through mus-
carinic and nicotinic receptors (23–25). Thus, the selective in-
volvement of muscarinic receptors to attentional modulation of
firing rates in primary visual cortex may be an anomaly, caused
by the unique expression pattern of cholinergic receptors in
macaque V1, where muscarinic receptors occur predominantly
on gamma-aminobutyric acid (GABA)ergic cells, while in
extrastriate cortex they also occur more frequently on pyramidal
cells (26–28), possibly in combination with variations in modu-
latory compartments, such as subcellular receptor expression
differences, differences in degradation pathways, or tissue tor-
tuosity across cortex (29). Based on the differences in cell type-
specific expression of cholinergic receptors (26, 27, 30–32) we
hypothesized that muscarinic and nicotinic receptors contribute
to neuronal signatures of attention in frontal cortex, possibly in a
cell type-dependent manner. To investigate this, we recorded
from FEF cells and performed pharmacological analysis of dif-
ferent ACh receptors by means of iontophoresis, while monkeys
performed a covert sustained spatial attention task. We found
that broad and narrow spiking cells required nicotinic and
muscarinic receptor activation to support normal excitability
(neuronal gain control). However, attentional rate modulation in
broad spiking FEF cells depended exclusively on muscarinic re-
ceptor activation, while in narrow spiking FEF cells it depended
on muscarinic and nicotinic receptor activation. Cluster analysis
revealed that muscarinic receptors contributed to attentional
modulation only in specific subgroups of broad spiking cells.
Equally, muscarinic and nicotinic receptors contributed to atten-
tional modulation only in specific subgroups of narrow spiking
cells. Our data reveal a cell type-specific contribution of cholin-
ergic receptors to attentional signals in primate frontal cortex.
Results
We recorded from 344 FEF cells from 2 monkeys, performing a
covert top–down spatial attention task under control conditions
and with ACh, scopolamine (Scop, muscarinic antagonist), or
mecamylamine (Mec, nicotinic antagonist) iontophoretically
applied. Animals had to fixate centrally on a computer screen,
while holding a touch bar. Following successful initial fixation,
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3 differently colored stimuli occurred on the screen, 1 centered
on the neuron’s receptive field (RF). After a variable time, a
color cue, displayed at fixation, indicated to the monkey which
stimulus to attend to. The animal had to monitor this stimulus
for luminance decrements (“dimming”) and ignore dimming of
the other stimuli. When the cued stimulus dimmed, the animal
had to release the touch bar to receive a fluid reward (Fig. 1A,
Methods, SI Appendix, and ref. 33). With 3 potential dimming
times, the animals had to monitor the cued stimulus throughout
the trial. Hit rates (SI Appendix) were 0.997 on average; i.e., ani-
mals missed fewer than 1/200 target dimmings (chance-level hit
rate = 0.33). Correct rejection rates (unreported distractor dim-
mings, SI Appendix) were 0.959; i.e., fewer than 1/20 distractor
dimmings were reported. This corresponds to d-prime values
of >4.3 for all stimulus locations. Thus, the animals performed the
task as intended, heeding the cue, ignoring irrelevant dimmings
and reporting target dimmings reliably (SI Appendix, Fig. S1).
For each cell we determined whether neuronal activity was
affected by attention (factor 1) or drug application (factor 2) or
whether there was an interaction between factors, using a 2-
factor ANOVA. The time period analyzed was from −500 ms to
0 ms before the time of the first dimming, which is the time
period where the difference between attend RF and attend away
conditions is maximal (single-cell examples, Fig. 2; population
data, SI Appendix, Fig. S6). Of 344 cells, 258 were broad spiking
cells (action potential peak-to-trough time [P2T] > 250 μs), and
86 were narrow spiking cells (action potential P2T ≤ 250 μs). Fig.
1B shows associated spike waveforms. Sixty-five of 86 (75.4%)
cells tested with ACh showed differential activity for attention
conditions, 68/86 (79.1%) cells were affected by drug application,
and 56/86 (65.1%) cells were affected by both. One hundred
sixteen of 136 (85.3%) cells tested with Scop showed differential
activity for attention conditions, 86/136 (63.2%) cells were affected
by drug application, and 74/136 (54.4%) cells were affected by both.
One hundred four of 122 (85.2%) cells tested with Mec showed
differential activity for attention conditions, 80/122 (65.5%) cells
were affected by drug application, and 68/122 (55.7%) cells were
affected by both (SI Appendix, Table S1).
Fig. 2 shows example attention and drug effects on neuronal
activity. Significance of activity differences was assessed by
comparing single-trial activity for different attention and drug
conditions, using a 2-factor ANOVA (F and P values reported
below). To obtain a single measure of attentional modulation we
calculated the area under the receiver operating characteristic
curve (AUROC, Methods; separately for drug off and drug on),
which indicates how well an ideal observer can decode the locus
of attention from single-trial firing rates, and we calculated
Cohen’s D (Methods).
ACh Effects on Example Cells. Fig. 2A shows raster plots and peri-
stimulus time histograms of an example broad spiking cell
(P2T = 415 μs) with and without ACh applied. Attending to the
RF resulted in a significantly higher firing rate than attending
away (F1,270 = 63.83, P < 0.001). ACh application increased
activity (F1,270 = 11.82, P = 0.001), but it reduced attentional
modulation (significant attention × drug interaction: F1,270 =
7.46, P = 0.007, AUROCno drug = 0.85, AUROCdrug = 0.67). Fig.
2B shows effects of ACh application on a narrow spiking cell
(P2T = 210 μs). Attention increased firing rates (F1,377 = 251.1,
P < 0.001), drug application increased firing rates (F1,377 = 36.72,
P < 0.001), and, atypically, it increased attentional modula-
tion (attention × drug interaction: F1,599 = 23.92, P < 0.001,
AUROCno drug = 0.84, AUROCdrug = 0.93).
Effect of Muscarinic Blockade on Example Cells. Fig. 2C shows ef-
fects of attention and muscarinic blockade on a broad spiking
cell (P2T = 409 μs). Attention to the receptive field increased
firing rates (F1,479 = 85.65, P < 0.001). Muscarinic blockade re-
duced activity (F1,479 = 82.41, P < 0.001), and it reduced atten-
tional modulation (attention × drug interaction: F1,479 = 9.82,
P = 0.002, AUROCno drug = 0.79, AUROCdrug = 0.69). Similar
results occurred for the narrow spiking cell (P2T = 194 μs) in Fig.
2D. Attention to the receptive field increased firing rates
(F1,371 = 88.07, P < 0.001). Muscarinic blockade reduced activity
(F1,371 = 177.1, P < 0.001), and it reduced attentional modula-
tion (attention × drug interaction: F1,371 = 23.34, P < 0.001,
AUROCno drug = 0.83, AUROCdrug = 0.63).
Effect of Nicotinic Blockade on Example Cells. Fig. 2E shows effects
of attention and nicotinic blockade on a broad spiking cell
(P2T = 275 μs). Attention to the receptive field increased firing
rates (F1,263 = 135.7, P < 0.001). Nicotinic blockade reduced
activity (F1,263 = 85.82, P < 0.001), and it reduced attentional
modulation (attention × drug interaction: F1,263 = 5.02, P =
0.026, AUROCno drug = 0.88, AUROCdrug = 0.85). Fig. 2F shows
the respective effects on a narrow spiking cell (P2T = 221 μs).
Attention to the receptive field increased firing rates (F1,380 =
175.8, P < 0.001). Nicotinic blockade reduced activity (F1,380 =
100.6, P < 0.001), and it reduced attentional modulation (at-
tention × drug interaction: F1,380 = 14.41, P < 0.001,
AUROCno drug = 0.91, AUROCdrug = 0.71).
Subdividing Broad and Narrow Cell Types. So far we have sub-
divided cells based on spike waveform width, in line with many
primate studies (e.g., refs. 7, 34, and 35), often assuming that
narrow spiking cells are (largely) inhibitory fast spiking inter-
neurons, while broad spiking cells are largely pyramidal cells.
However, almost all pyramidal cells in macaque motor cortex
Fig. 1. (A and B) Cartoon of the task (A) and recorded spike waveforms (B). (A) Monkeys fixated centrally. Five hundred milliseconds after fixation onset
3 colored gratings were presented equidistant from the fixation spot. One of the gratings was placed in the receptive field of the neuron under study. After a
variable time (300 to 1,400 ms) a central colored cue indicated which stimulus was behaviorally relevant on the current trial. The animal had to covertly monitor
this stimulus and wait for it to change luminance (referred to as target dimming). The target dimming could occur first, second, or third in the sequence of
dimming events (Left to Right). Distracter dimming had to be ignored by the monkey. Detection of target dimming was indicated by releasing a hand-held touch
bar. (For additional details see Methods). (B) Normalized spike average waveforms of all narrow (turquoise) and all broad (purple) spiking cells recorded.
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M1 express Kv3.1b potassium channels and have the potential to
be narrow spiking (36). Moreover, a large majority of macaque
prefrontal cortex inhibitory interneurons are not parvalbumin-
positive fast spiking neurons and have broad spiking waveforms
(37–41). Finally, calretinin- and calbindin-positive fast spiking
interneurons exist (39). Thus, the narrow–broad divide benefits
from further subdivision, with additional physiological charac-
teristics taken into account. To do so, we performed cluster
analysis (42). For cluster identification we used P2T, coefficient
of variation (CV) of the interspike interval (ISI), coefficient of
variation of neighboring ISIs (CV2), local variation (Lv) of the
ISI, firing rate, variability of firing rate (Fano factor [FF]), and
strength of attentional modulation (AUROC) (details in Meth-
ods and SI Appendix). We included parameters that together
explained at least 90% of the variance (SI Appendix and ref. 42).
This left P2T, CV2, Lv, FR, and AUROC as clustering param-
eters. Including AUROC as a clustering parameter means that
clustering was performed on physiological and functional prop-
erties. We believe this is justified, as our aim was to determine
whether cholinergic drugs differently affect different cell types
(including dissociating between cells more and less strongly af-
fected by attention). We used the Akaike information criterion
(AIC) and the Bayesian information criterion (BIC) to select the
appropriate number of clusters. AIC and BIC allow model se-
lection based on how well a model fits the data, relative to al-
ternative models. We tested n = 2, 3, .. to 12 clusters. Based on
AIC, data were optimally divided into 7 clusters. Based on BIC
data were optimally divided into 6 clusters (SI Appendix). Di-
viding cells into 6 clusters resulted in more mixing of broad and
narrow spiking cells within single clusters. This was much re-
duced using 7 clusters (SI Appendix, Fig. S5). Since broad and
narrow spiking is a well-established criterion to subdivide cell
classes, we used 7 clusters for further analysis. Four of 7 cell
clusters contained almost exclusively (a single exception) broad
spiking cells (B1 to B4; SI Appendix, Fig. S5A). Two cell clusters
predominantly contained narrow spiking cells (N1 and N2; dis-
tribution of waveform width in SI Appendix, Fig. S5A, Right), and
1 cell cluster contained an approximately equal number of nar-
row and broad spiking cells (N3; SI Appendix, Fig. S5A). Spike
waveform distribution for N3 was not unimodal (calibrated
Hartigan’s dip test, false discovery rate [FDR]-adjusted P <
0.001). None of the other waveform distributions were signifi-
cantly bi/multimodal (calibrated Hartigan’s dip test, all FDR-
adjusted P > 0.1). For details regarding physiological and func-
tional differences between cell clusters see SI Appendix, Fig. S6.
Next we describe how cholinergic modulation affected cell sep-
aration along the dichotomic broad–narrow divide, followed by
how it affected clusters B1 to B4 and N1 to N3.
Drug Effects on General Neuronal Activity. To assess how drug ap-
plication affected neuronal excitability we compared attend
RF as well as attend away firing rates with and without drug
applied. We first describe results when separately analyzing
broad and narrow spiking cells. We analyzed drug effects with
activity aligned to stimulus onset, to cue onset, and to time of
first dimming. Cells significantly affected by drug applica-
tion were included (2-factor ANOVA, main effect of drug or
drug × attention interaction; see SI Appendix, Table S1 for
A C E
B D F
Fig. 2. (A–F) Single-cell examples of cholinergic modulation of firing rates and of attentional effects for broad (A, C, and E) and narrow (B, D, and F) spiking
cells, when acetylcholine, scopolamine, or mecamylamine was applied. Shown are raster plots and peri-stimulus time histograms relative to the time of the
first dimming, separately for the 2 attention and 2 drug conditions (color coded). Attention to the receptive field, no drug condition, light red; attention away
from the receptive field, no drug condition, light green; attention to the receptive field, drug condition, dark red; and attention away from the receptive
field, drug condition, dark green.








sample sizes). ACh significantly increased firing rates in both
attention conditions (attend RF and attend away), in broad and
narrow spiking cells and all 3 analysis periods (all FDR-corrected
P values <0.001, 2-sided t test; for exact numbers and t statistics
see SI Appendix, Table S2). Scop and Mec significantly decreased
firing rates (all FDR-corrected P values <0.001, 2-sided t test; for
exact numbers and t statistics see SI Appendix, Table S2). To
quantify effects across attention conditions we calculated a drug
modulation index (MI),

Drug  MI = rateno  drug − ratedrugrateno  drug + ratedrug

. Drug MI
histograms (along with means and SDs) for broad and narrow
spiking cells are shown in Fig. 3. ACh application generally in-
creased firing rates, and thus drug MI distributions were on av-
erage negative and significantly different from 0 (P < 0.001,
2-sided t test, both cell types, all response periods, FDR cor-
rected for multiple comparisons). Mean drug MIs of narrow and
broad spiking cells were not significantly different (t(1, 68) =
−0.956, P = 0.340, 2-sided t test, FDR corrected for multiple
comparisons). With Scop applied drug MIs were on average
positive and significantly different from 0 (P < 0.001, 2-sided
t test, both cell types, all response periods, FDR corrected for
multiple comparisons), reflecting the suppressive action of
muscarinic receptor blockade. Narrow spiking cells had signifi-
cantly larger drug MIs than broad spiking cells (predimming
period: t(1,83) = 2.956, P = 0.007, 2-sided t test, FDR corrected
for multiple comparisons); i.e., narrow spiking cells were more
strongly modulated by muscarinic blockade than broad spiking
cells. This difference occurred for all 3 response periods (Fig. 3,
Insets). The difference in muscarinic blockade efficacy on the
2 cell types was not a consequence of differential firing rates
between narrow and broad spiking cells (SI Appendix). Nicotinic
blockade equally resulted in positive drug MIs for both cell types
(P < 0.001, 2-sided t test, both cell types, all response periods,
FDR corrected for multiple comparisons), but there was no
significant difference of drug MIs between the 2 cell types
(t(1,78) = 1.65, P = 0.121, FDR corrected for multiple com-
parisons, 2-sided t test). Thus, nicotinic blockade reduced the
excitability in narrow and in broad spiking cells similarly.
We can exclude the possibility that differing levels of drug
application account for the drug results on firing rates or on
attentional modulation in narrow vs. broad spiking cells (details
SI Appendix, where we analyze effect of drugs on cells as a
function of application current and of firing rates).
All of the reported results were unchanged when non-
parametric tests (sign rank test and rank sum tests) were
employed instead of the parametric t test.
We next analyzed how drug application affected cell clusters
B1 to B4 and N1 to N3 (SI Appendix, Fig. S8). ACh differentially
affected the different clusters (F(6,63) = 3.72, P < 0.001, 1-way
ANOVA, SI Appendix, Fig. S8). Excitability was not differentially
affected by muscarinic (F(6,73) = 0.3, P = 0.935, 1-way ANOVA)
or nicotinic blockade (F(6,69) = 1.06, P = 0.393, 1-way ANOVA)
across the 7 cell clusters. This is likely a consequence of di-
minished sample sizes that occur with clustering. To follow up on
this, we calculated effect size of drug application (SI Appendix).
Effect size of drug application between clusters often differed
more than those between broad and narrow spiking cells, where
statistical differences were found upon muscarinic receptor
blockade (SI Appendix, Table S3).
Drug Effects on Attentional Modulation of Neuronal Activity. At-
tentional modulation emerged after cue onset, and it was most
pronounced when the activity was aligned to the time of the first
dimming (see Fig. 2 and SI Appendix, Fig. S7 for single-cell and
population examples). Attention to the receptive field increased
firing rates and attention away from the receptive field decreased
firing rates relative to the precue activity levels (SI Appendix, Fig.
S7, cue alignment). However, at the single-cell level some cells
decreased their activity during attend RF conditions relative to
precue activity and in some cases also relative to attend away
conditions, as reported previously (33).
We first describe effects of cholinergic contributions to at-
tentional modulation separately for narrow spiking and broad
spiking cells. We quantified attentional modulation by calculat-
ing the AUROC for the attend RF vs. attend away conditions, as
well as by calculating Cohen’s d′. We included cells where drug
application had a significant effect on neuronal activity and
where attention had a significant effect on neuronal activity, as
Fig. 3. Effect of cholinergic drugs on neuronal excitability, quantified through drug MIs (averaged across attention conditions). Data for broad spiking cells
are shown by black outlined histograms and black stars and SEM and those for narrow spiking cells by gray shaded histograms and gray dot and SEM. The
3 different drug conditions are shown separately for the dimming (dim) aligned response period as histograms. Means and SDs are shown as shaded circles
and open stars. False discovery rate-corrected P values (along with t statistics and sample sizes) indicate whether broad and narrow spiking cells were dif-
ferently affected by the drug application. Insets above the histograms show the means and SDs for the period after stimulus onset (stim) and the period after
cue onset (cue).
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we were interested in the drug effect (factor 1) on attentional
modulation (factor 2) of firing rates. We focused on the time
period before the first dimming, as attentional modulation was
strongest for this period, and our interest was to determine how
this was affected by the drug of interest.
Given that both factors affected the majority of cells (SI Ap-
pendix, Table S1), including all cells (even those where 1 of the
2 factors was not significant) yielded qualitatively similar results,
with similar significance levels. Attentional AUROC significantly
depended on drug application (F(3,382) = 11.8, P < 0.001,
mixed-model [MM-]ANOVA) and cell type (F(1,382) = 6.8, P =
0.009, MM-ANOVA). Moreover, there was a significant in-
teraction between drug application and cell type (F(3,382) = 3.5,
P = 0.016, MM-ANOVA; the factor “attention” is included in
the single dependent variable AUROC and is thus not a sepa-
rable factor in the ANOVA). To understand how different drugs
affected attentional modulation, we separately analyzed atten-
tional modulation given the drug applied for broad and for
narrow cells. As stated previously, this was done on the cell
sample where attention and drug application significantly af-
fected firing rates.
Fig. 4A shows attentional AUROC values for the 3 drug
conditions for broad and narrow spiking cells. Narrow spiking
cells showed larger attentional AUROC values than broad
spiking cells (t(1,193) = −3.574, P < 0.001, 2-sided t test). ACh
application resulted in reduced AUROCs in broad spiking cells
(t(1,46) = 3.706, P < 0.001, 2-sided t test). This was because
attend away condition activity increased more than attend RF
condition activity (t(1,46) = −3.217, P = 0.002, comparison of
drug-induced activity change for attend RF conditions vs. attend
away conditions, 2-sided t test). No differences were found in
narrow spiking cells (t(1,7) = 0.308, P = 0.767, 2-sided t test).
Blocking muscarinic receptors reduced attentional AUROCs in
broad and narrow spiking cells (t(1,56) = 2.127, P = 0.038 and
t(1,15) = 2.510, P = 0.024, respectively, 2-sided t test, Fig. 4A).
Blockade of nicotinic receptors reduced attentional AUROCs
only in narrow spiking cells (t(1,23) = 2.827, P = 0.010, 2-sided
t test), not in broad spiking cells (t(1,42) = 1.628, P = 0.111, 2-
sided t test). Thus, muscarinic receptor activation is required for
attentional modulation of firing rates in both cell types, while
nicotinic receptor activation is required only for attentional
modulation of firing rates in narrow spiking, but not in broad
spiking cells.
In Fig. 4A a minority of cells show AUROC values of <0.5 in
the no drug condition. This occurred in cells which showed ac-
tivity reduction after cue onset, whereby the reduction was larger
for attend RF than for attend away conditions. It might be argued
that for these cells the AUROC should be calculated as (1 −
AUROC). Doing so does not change the conclusions (see SI
Appendix for associated P values).
Similar, but not fully identical, results occurred when we
quantified attentional modulation using Cohen’s D. ACh re-
duced attentional Cohen’s D in broad spiking cells (t(1,46) =
2.489, P = 0.017, 2-sided t test), but not in narrow spiking cells
Fig. 4. Attentional modulation quantified by calculating the AUROC when no drug (abscissa) was applied and when the drug of interest was applied
(ordinate). (Top row) Red data points delineate AUROC values of narrow spiking cells and black data points those of broad spiking cells. Significance of effects
is given by the P-value Insets. n denotes sample sizes. (Bottom rows) Attentional modulation (AUROC) for the different cell clusters in the absence and
presence of different drugs. The different cell clusters (B1 to B4 and N1 to N3) are indicated through different colors and symbols (tabulated along with
sample sizes and significance of drug effects at the bottom of each subplot). Insets in the scatterplots show the further subdivision of the N3 group into cells
that were of narrow spiking type and those that were of broad spiking type (B5). Boxes at the bottom of the subplots show associated sample sizes along with
t statistics (provided n ≥ 6) regarding the drug effects on attentional modulation. n denotes sample sizes.








(t(1,7) = −0.183, P = 0.860, 2-sided t test). Muscarinic receptors
blockade significantly reduced attentional Cohen’s D in narrow
spiking cells (t(1,15) = 3.169, P = 0.007, 2-sided t test), but not in
broad spiking cells (t(1,56) = 1.384, P = 0.172, 2-sided t test).
Nicotinic receptors blockade significantly reduced attentional
Cohen’s D in narrow spiking cells (t(1,22) = 2.14, P = 0.044, 2-
sided t test), but not in broad spiking cells (t(1,43) = 1.188, P =
0.241, 2-sided t test).
We next performed this analysis for cell clusters B1 to B4 and
N1 to N3. ACh reduced attentional modulation in clusters B1 and
B4, but did not affect attentional modulation in the other clusters
(see Fig. 4 for visualization and all t statistics). Some of these null
results may be due to reduced sample sizes caused by clustering.
We thus calculated effect sizes to allow for more sample size-
independent comparisons (SI Appendix, Table S4). Muscarinic
blockade significantly reduced attentional modulation in clusters
B1, B3, B4, and N1, with trending effects for N3 (Fig. 4). These
trending results prevailed when we further subdivided N3 into the
narrow (P = 0.083, Fig. 4) and broad spiking groups (not tested
due to small sample size; n = 3). Nicotinic receptors blockade
resulted in a significant reduction of attentional modulation in
cluster N3, which was predominantly driven by an AUROC re-
duction in the narrow spiking subgroup of N3 (Fig. 4, Insets). Mild
trends also occurred for cluster B2 (Fig. 4). However, if anything,
nicotinic blockade increased attentional modulation in this sub-
group (most data points were above the diagonal).
Firing Rate Variability as a Function of Attention and Drug Application.
Attention reduces firing rate variability in addition to affecting
firing rates of neurons in visual cortex (7–9). Rate variability was
quantified by calculating gain variance (33, 43). For justification of
using this measure (and its comparison to Fano factors) see SI
Appendix. We calculated gain variance as a function of attention
and drug application for each cell (Fig. 5). Gain variance signifi-
cantly depended on cell type (F(1,473) = 29.9, P < 0.001, mixed-
model ANOVA, main effect of cell type). It was lower in narrow
spiking cells (t(1,213) = −2.326, P = 0.021, 2-sided t test FDR-
corrected post hoc comparison). Location of attention had a sig-
nificant main effect on gain variance (F(1,473) = 20.1, P < 0.001,
mixed-model ANOVA, main effect of attention, Fig. 5). Attention
to the neuron’s RF resulted in lower gain variance (t(1,242) =
−4.834, P < 0.001, 2-sided paired t test, FDR-corrected post hoc
comparison). Moreover, drug application significantly affected
gain variance (F(1,473) = 7.0, P < 0.001, mixed-model ANOVA,
main effect of drug). In addition, there was a trend toward a cell
type × drug interaction (F(3,473) = 2.3, P = 0.08, mixed-model
ANOVA), and there was a significant interaction between cell
type, attention, and drug (F(3,473) = 3.5, P = 0.015, mixed-model
ANOVA). Other interactions were not significant. The significant
interaction might suggest that the effect of a specific drug on gain
variance differed between attention conditions. However, this was
not the case when analyzed individually for the 3 drugs (cell type ×
attention × drug interaction: ACh F(1,209) = 0.4, P = 0.539; Scop
F(1,197) = 0.3, P = 0.589; Mec F(1,181) = 0.7, P = 0.396). Thus,
the effect of the drug on gain variance did not differ between
attention conditions in narrow or broad spiking cells (additional
details in SI Appendix, Fig. S9).
Post hoc testing to determine how the different drugs affected
gain variance revealed that ACh did not affect gain variance (see
Fig. 5 and SI Appendix, Table S6 for exact P values, means, and
SEM). Scop and Mec significantly increased gain variance in
broad and narrow spiking cells (see SI Appendix, Fig. S8 and
Table S6 for exact P values, means, and SEM).
Next, we calculated drug gain variance MIs to deter-
mine whether gain variance was more affected by drug ap-
plication in narrow than in broad spiking cells:
Drug  Gain  MI = Gain  Varno  drug − Gain  VardrugGain  Varno  drug + Gain  Vardrug

. No significant differences
Fig. 5. Neuronal variability quantified by gain variance for the different drug and attention conditions. (Top row) Effect of attention on gain variance under
control conditions (blue) and when the drug of interest was applied (red). (Bottom row) Effect of drug application under the 2 attention conditions (green,
attention to the RF; black, attention away from the RF). Left column shows data for experiments where ACh was applied, Center column shows data when
scopolamine was applied, and Right column shows data when mecamylamine was applied. Circles show data for narrow spiking cells and asterisks data for
broad spiking cells.
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were found with ACh applied (t(1,70) = −0.504, P = 0.616, 2-sided
t test, broad drug gain MI 0.15 ± 0.06 SEM, narrow drug gain MI
0.23 ± 0.13 SEM). However, gain variance increase was larger in
narrow than in broad spiking cells with muscarinic receptors blocked
(t(1,80), = 2.084, P = 0.040, broad drug gain MI −0.08 ± 0.05 SEM,
narrow drug gain MI −0.33 ± 0.13 SEM) and with nicotinic receptors
blocked (t(1,88), = 2.058, P = 0.043, broad drug gain MI −0.13 ± 0.05
SEM, narrow drug gain MI −0.30 ± 0.06 SEM). For distributions of
drug gain MIs see SI Appendix, Fig. S10.
Finally, we determined whether attention or drug application
differently affected gain variance in cell clusters B1 to B4 and
N1 to N3. Attention MIs of gain variance were determined for
control and drug-applied conditions. Attentional MI of gain
variance significantly differed between different cell clusters
(mixed-model ANOVA, effect of cell cluster: F(6,128) = 10.1,
P < 0.001), but there was no effect of drug application on the
attentional modulation of gain variance (effect of drug:
F(1,128) = 1.8, P = 0.122), and there was no interaction (cell
type–drug interaction: F(12,128) = 0.6, P = 0.801). Thus, while
drugs affected gain variance, they did not affect the attentional
modulation thereof. This differs from their effect on attentional
rate modulation (presented above). For additional details see SI
Appendix, Fig. S11.
Drug Effects on Behavioral Performance. Given the local drug ap-
plication, we did not expect drugs to alter performance. While
this proved true for hit and correct rejection rates (SI Appendix,
Fig. S1), drug application affected reaction times (RTs). We
normalized RTs from each session relative to the session mean.
This was done as stimulus size and stimulus location varied with
RF location and size, which affected RTs between sessions. ACh
application showed a trend of reducing RTs (2-factor ANOVA,
drug F(1,19574) = 3.0, P = 0.082, attention F(1,19574) = 0.4, P =
0.531, drug × attention F(1,19574) = 2.4, P = 0.123). This trend
appeared to be restricted to the attend RF condition (SI Ap-
pendix, Fig. S12 and Table S7).
Blocking muscarinic receptors caused a significant interaction
between the locus of attention and drug application (attention ×
drug: F(1,31641) = 5.0, P = 0.025, 2-factor ANOVA), by in-
creasing RTs for the attend RF condition (t(1,10546) = 2.157, P =
0.031, 2-sided t test; SI Appendix, Fig. S12 and Table S7), but not
for attend away conditions (t(1,21091) = −0.857, P = 0.315, 2-
sided t test). Blockade of nicotinic receptors resulted in a
trending interaction between the locus of attention and drug ap-
plication (F(1,25980) = 3.3, P = 0.069, ANOVA), which differed
from the effects seen when Scop was applied. With nicotinic re-
ceptors blocked, attend RF RTs were not affected, while attend
away RTs showed a mild trend of being increased (t(1,17314)
= −1.679, P = 0.090, 2-sided t test; SI Appendix, Fig. S12 and
Table S7).
Discussion
Acetylcholine affects the excitability of broad and narrow spiking
cells in FEF by activating muscarinic and nicotinic receptors.
Muscarinic receptor activation in broad and narrow spiking cells
contributes to attentional modulation of firing rates, while nic-
otinic receptors contribute to attentional modulation only in
narrow spiking, but not in broad spiking cells. Activation of both
receptor types reduces firing rate variability. The effects were
restricted to specific subgroups of narrow and broad spiking
cells, which differentiate along the dimensions of attentional
modulation, firing rate, and regularity of spiking. These data
demonstrate that both receptor types are important in generat-
ing attentional signals in FEF, even if muscarinic activation was
more critical. The latter is underscored by the finding that
blockade of muscarinic receptors increases reaction times for
attend RF conditions, which was not found when nicotinic re-
ceptors were blocked.
Cholinergic Contribution to Neuronal Excitability. In line with pre-
vious studies (20, 44–50) ACh increased neuronal excitability.
The increased excitability is caused by muscarinic and nicotinic
receptor activation in broad and narrow spiking cells. Excitability
was more strongly dependent on muscarinic receptors in narrow
spiking cells than in broad spiking cells. Does that mean parvalbumin
positive (PV) interneurons in FEF are more susceptible to musca-
rinic activation than other cell types? Almost certainly not. While
GABAergic parvalbumin fast spiking interneurons are generally
narrow spiking neurons, the opposite cannot be inferred. Narrow
spiking cells comprise different cell types (51, 52) and in primates are
often even long-range projecting pyramidal cells (36, 53). Thus, a
large fraction of the narrow spiking cells in our sample are likely
pyramidal cells, narrow spiking calbindin cells, and potentially others.
This is corroborated by the cluster analysis, which yielded 3 different
narrow spiking cell groups, whereby only 1 cluster exhibited features
generally assigned to fast spiking PV interneurons, namely high firing
rates and relatively regular interspike intervals (small Lv values). The
other 2 cell groups consisting mostly of narrow spiking cells (N1 and
N2) show activity characteristics that are rather different and
are thus probably different cell types (possibly narrow spiking
pyramidal cells and narrow spiking calbindin/calretinin cells).
However, cluster N3, which exhibited features often assigned to PV
interneurons, consisted of different cells with respect to the spike
waveform width. One subgroup exhibited very narrow spikes.
The other subgroup had slightly wider spikes, which usually fall
into the broad spiking category. It is tempting to speculate that
the narrow subgroup from cluster N3 mostly consists of PV fast
spiking interneurons. This would match the number of PV cells
expected to occur in an opportunistic sample of cell recordings.
Twenty-five percent of cortical neurons are inhibitory cells (40),
of which ∼25% are PV neurons (40); an opportunistic sampling
would yield 6.25% PV cells in randomly recorded cells from the
cortex. The narrow spiking cells from the N3 group constitute
6.9% of all recorded cells, which is in good agreement with this
expectation. However, microelectrodes have a sampling bias for
larger cells/action potentials and we would expect to undersample
PV cells, with even fewer PV cells than narrow spiking cells pre-
sent in the N3 cluster. Given these considerations, it is impossible
to prove that the N3 sample indeed consists of PV interneurons.
It is even more difficult to assign morphologically or immuno-
histochemically identified cell types to other clusters and thus
to specific cholinergic modulation. The majority of GABAergic
interneurons express muscarinic receptors in V1 of the primate,
while only few excitatory (pyramidal) cells show muscarinic ex-
pression (26). In rodents, muscarinic receptors are more strongly
expressed on somatostatin and VIP interneurons than on PV
interneurons (54). Since the former 2 types are generally broad
spiking, one might expect broad spiking cell excitability to be
more affected by muscarinic blockade than narrow spiking cell
excitability. Conversely, we found that cell excitability in narrow
spiking cells was more strongly affected by muscarinic blockade
than broad spiking cell excitability. This is not necessarily sur-
prising for 2 reasons. First, the expression level of muscarinic
receptors in excitatory cells increases with cortical hierarchy of
the primate, at least when considering V2, area MT, and dor-
solateral prefrontal cortex (DLPFC) (26, 28, 55, 56), and thus
differences are expected for FEF as well. Second, substantial
differences exist in cell type-specific expression of cholinergic
receptors between primates and rodents (30). Thus, if a large
proportion of pyramidal cells express muscarinic receptors in the
FEF, and many of these were narrow spiking (36, 53), our result
is not necessarily surprising anymore. However, these scenarios
remain speculative.
Without the use of more specific muscarinic agonists and
antagonists it is currently impossible to argue which muscarinic
receptor subtype might be responsible for our findings. In
neighboring DLPFC (area 46), muscarinic M1 and M2 receptors








are expressed postsynaptically on symmetric and less often on
asymmetric synapses on excitatory cells, but also occur on inter-
neurons (55, 56). Based on figures 1–3 of ref. 56, similar results
appear to be the case for M2 receptor expression in FEF.
M1 activation results in increased layer V pyramidal cell excitability
in prefrontal and sensory cortex of rodents (57, 58). Moreover,
activation of M2 receptors results in reduced inhibitory postsynaptic
currents, which can have a net effect on increased cell excitability
across the population due to the reduction in inhibitory efficacy
(58). The reduced excitability of FEF cells in our sample upon
muscarinic blockade could thus have been caused by either receptor
subtype. Further studies with more specific antagonists and agonists
are required to delineate the individual receptor contributions,
ideally in combination with cell type-specific labeling techniques
(e.g., photo tagging of specific cell types).
Cholinergic Contribution to Attentional Rate Modulation. In FEF
ACh contributes to attentional signals through muscarinic re-
ceptors in broad and narrow spiking cells, while nicotinic re-
ceptors contribute to attentional signals only in narrow spiking
cells. ACh contributes to attentional rate modulation through
muscarinic receptors in area V1, while nicotinic receptors do not
(20). Ref. 20 does not differentiate between broad and narrow
spiking cells. In principle, nicotinic receptors might also exclu-
sively contribute to attentional modulation in narrow spiking
cells in area V1, given that fewer cells are of the narrow spiking
type. Mixing a relatively small number of affected narrow
spiking cells with a comparatively large number of nonaffected
broad spiking cells might eliminate the significance of any
changes. However, nicotinic blockade in the Herrero et al. (20)
dataset did not result in even a hint of attention-induced rate
change reduction (figure 4 in ref. 20), suggesting there may be
genuine differences between area V1 and FEF.
The result that nicotinic receptors do not contribute to at-
tentional modulation in FEF broad spiking cells might seem
somewhat surprising, given the involvement of nicotinic (α7)
receptors in spatial working memory delay activity, through in-
teraction with NMDA receptors on layer 3 DLPFC pyramidal
cells (59). But this surprise is under the premise that pyramidal
cells in FEF are of broad spiking type and based on the premise
that spatial working memory and spatial top–down attention are
related concepts (which we believe is the case). Analyzing at-
tentional modulation by nicotinic blockade for the different cell
clusters showed that none of the different broad spiking cells
alter their attentional modulation when nicotinic receptors were
blocked, but pyramidal cells in frontal cortex can be of narrow
spiking type (53). Changes of attentional modulation occurred
only in the N3 cluster, which comprised a broad and a narrow
spiking subgroup. The narrow spiking subgroup of N3 exhibits
features compatible with fast spiking PV interneurons. However,
these features have been studied in slices from nonprimates. It
remains to be determined whether the differences in spike width
between primate motor/premotor pyramidal cells and equivalent
(rat) cells (36, 53) map onto other activity characteristics as well.
Caution is needed to argue that the nicotinic contribution to
attentional modulation is mediated through narrow spiking PV
interneurons, as we would expect this to “spill over” to pyramidal
cell types due to their inhibitory effect on neighboring pyramidal
cells. Thus, if our drug manipulations affect nearby PV cells, this
effect should also be seen in pyramidal cells, due to the strong
coupling of PV cell activity to pyramidal cell activity.
The relative contribution of muscarinic and nicotinic receptors
to attentional rate modulation in FEF cells is matched by be-
havioral studies in humans, where ACh contributes to attention
predominantly through muscarinic receptor activation. However,
synergistic effects between nicotinic and muscarinic receptor
activation were also found (60). Other studies have demon-
strated a direct role of α7 nicotinic receptors in sustained at-
tention in mice (61). Our study points to a more profound role of
muscarinic receptors in FEF in attentional control also at the
behavioral level. Muscarinic blockade affected behavior in our
animals, increasing reaction time, while nicotinic blockade had
no effect. We currently do not know whether M1 or M2 mus-
carinic receptors are responsible for these effects. M1 receptors
are not responsible for maintenance of working memory signals
in a rule-based saccade task in DLPFC (62). The effects seen in
our study might thus be mediated by M2 receptors, but it remains
to be seen whether the same dependencies apply to a spatial
attention task in FEF. We did not employ combined blockade of
nicotinic and muscarinic receptors, but the results by Ellis et al.
(60) suggest that combined blockade might result in stronger
behavioral effects.
Rate variability, as measured by gain variance (43), in broad
and in narrow spiking cells was reduced by attention, as pre-
viously reported for FEF (33) and area V4 (63). Application of
ACh reduced gain variance in broad and narrow spiking cells.
Blockade of muscarinic and of nicotinic receptors increased gain
variance. Theoretical work suggests that neural variability in
neuronal attractor networks during spontaneous activity is high
because the attractor networks operate close to criticality, a
point where the network is close to a boundary where input noise
induces large fluctuations between multiple—unstable—network
states (64). Stimulus presentation and directed attention increase
excitatory drive and move neurons away from the point of in-
stability (the bifurcation point), thereby stabilizing 1 specific
attractor, reducing transitions between different attractor states.
This in turn results in a net decrease in neural variability. Our
data show that cholinergic activation of muscarinic or nicotinic
receptors decreases neuronal excitability, and conversely their
blockade results in increased neuronal variability. The excitation
induced by stimulus presentation and/or attention is less effective
when cholinergic receptors were blocked, resulting in less stable
attractor states. Changes in attractor and brain states depend on
neuromodulator tone (3, 49, 65–69). We argue that ACh sup-
ports attentional states by increasing desynchronized brain states
(70). This favors stable attractor configurations (e.g., directions
of attention) which are less prone to external perturbation
(distractions). In mouse visual cortex these state changes are
critically dependent on somatostatin-positive interneurons (71).
Whether similar mechanisms are at work in FEF is unknown.
Comparison to Other Transmitters/Neuromodulators. While musca-
rinic and nicotinic receptor blockade increased rate variability in
FEF, it did not affect the attentional modulation thereof.
However, blockade of either receptor altered attention-induced
rate changes. In area V1 attention-induced alterations of rate
variability are dependent on NMDA receptor activation (8).
Whether NMDA receptor activation has similar effects in area
FEF is currently unknown. Drug infusion studies into FEF sug-
gest that dopamine affects behavior and activity in area V4 by
acting on FEF D1 receptors, causing effects similar to those of
attention (72). This occurs by affecting the strength of inputs to
and recurrent connectivity within FEF (73). In DLPFC dopa-
mine, NMDA, α7 nicotinic receptors, and noradrenergic α2a
receptors play important roles in the generation of spatial
working memory signals (59, 74, 75). These are conceptually
related to covert spatial attention signals. By acting on
D1 receptors dopamine supports working memory-related ac-
tivity through noise reduction (76), while noradrenergic α2a re-
ceptor activation enhances working memory-related activity
through signal enhancement (75). NMDA and α7 nicotinic re-
ceptor activation are required to generate persistent delay ac-
tivity in the absence of sensory stimulation (59, 74). Our data
suggest that cholinergic stimulation in FEF has a role similar to
α2a and NMDA receptor activation, supporting a persistently
enhanced activity of the attended stimulus. Together these
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studies suggest that it is the combined action of multiple trans-
mitter/neuromodulator systems that shapes the frontal network
activity, thereby supporting cognitive functions. In relation to
cholinergic influences, our study shows that attentional signal
generation in FEF is more reliant on muscarinic receptors and
less on nicotinic receptors. This difference may have implications
for future treatment strategies of attentional dysfunction.
Methods
Experimental Procedures. Procedures were approved by the Newcastle Uni-
versity Animal Welfare Ethical Review Board (AWERB) and carried out in
accordance with the European Communities Council Directive RL 2010/63/EC,
the US National Institutes of Health Guidelines for the Care and Use of
Animals for Experimental Procedures, and the UK Animals Scientific
Procedures Act.
Surgical preparation. Monkeys were implanted with a headpost and recording
chambers over area FEF under sterile conditions and under general anes-
thesia, as published in detail previously (77).
Identification of recording sites. Area FEF was identified by means of structural
MRI. FEF recording sites were confirmed by visual RF size and topography (78),
by memory-guided saccade responses, by saccade-related responses to the
visual/motor field, and by means of low-current (50 μA) electrical saccade
induction (78). Additionally recording sites in area FEF were verified in his-
tological sections stained for cyto- and myeloarchitecture (79).
RF and saccade field mapping. The location and size of the RF were measured by
a reverse correlation method (80). Saccade fields (SFs) were mapped as de-
scribed in ref. 33.
Behavioral task and stimuli. All details about the task and stimuli have been
published previously; for ease of access they are repeated in SI Appendix.
Electrophysiological Recordings and Drug Application. Drugs were applied
iontophoretically using a tungsten-in-glass electrode flanked by 2 pipettes
(77). For details regarding electrodes, cell inclusion, and number of trials
available under different drug conditions see SI Appendix.
Data Collection. Stimulus presentation and behavioral control were managed
by Remote Cortex 5.95 (Laboratory of Neuropsychology, National Institute
for Mental Health, Bethesda, MD; http://dally.nimh.nih.gov/). Neuronal data
were collected by Cheetah data acquisition (Neuralynx) interlinked with
Remote Cortex. For details regarding data acquisition and postprocessing
see SI Appendix.
Data Analysis. We analyzed neuronal activity associated with correct trials.
We aligned neuronal activity to the stimulus, to the cue, and to the first
dimming onset. To analyze the effects of attention on neuronal firing rate,
we analyzed the activity from −500 ms to 0 ms before the first dimming.
Given that there were 3 attention conditions (attend RF and 2 attend away
conditions), 2 different stimulus motion directions, and 2 drug conditions
(applied vs. not applied) we had 6 conditions total for each drug condition.
We calculated a 3-factor ANOVA for the predimming activity to determine
whether attention, drug application, and direction of motion had a signif-
icant effect on neuronal activity and whether there was a significant in-
teraction between any of these factors. Cells with a significant main effect of
attention or a significant interaction (P < 0.05) were classified as attention
modulated; cells with a significant main effect of drug application or an
interaction of drug applications with any of the other factors were classified
as drug modulated.
Quantification of Attentional Modulation. The strength of attentional mod-
ulation was quantified using an ideal observer-based approach, whereby we
calculated the AUROC separately for the no drug condition and the drug
condition. It is based on signal detection theory which calculates the overall
probability that a random sample of neuronal activity (i.e., spikes per second)
selected during one attention condition is larger than a sample selected in the
alternative attention condition (81–83).
Quantification of Drug Effects. Drug effects were assessed by calculating a
drug MI for each stimulus condition and for each analysis period (100 to
400 ms after stimulus onset, 100 to 400 ms after cue onset, and −500 to
0 before the first dimming):
Drug  MI=
Activity   no  drug  − Activity   drug
Activity   no  drug + Activity   drug
.
Gain Variance Analysis. To investigate to what extent the different drugs
affected attention-induced changes in response reliability, we used both
Fano factor and gain variance analysis (43). In gain variance analysis, the
single-trial rate (count data) is fitted with a negative binomial, which yields a
gain variance term. This captures the magnitude of the change in excitability
from trial to trial. We used the 2 attend RF conditions to obtain an estimate
of the attend RF gain variance and the 4 attend away conditions to obtain
an attend away gain variance estimate. Gain variance terms were then av-
eraged for the 2 attend RF conditions and separately for the 4 attend away
conditions. This was done separately for the drug applied and drug not
applied conditions.
Cluster Analysis. We followed the procedures published by Ardid et al. (42)
and used the open source Matlab resources (https://bitbucket.org/sardid/
clusteringanalysis) with minor modifications to suit our data. For all details
regarding the cluster screening, the parameters used for final clustering, and
the clustering itself see SI Appendix, Methods.
Analysis of Behavioral Data. We calculated control condition and drug con-
dition reaction times and error rates for each experimental session where a
significant effect of drug application was found at the cellular level. For
details see SI Appendix.
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